z-logo
open-access-imgOpen Access
Recurrent Central Serous Retinopathy with Permanent Visual Loss in a U.S. Naval Fighter Pilot
Author(s) -
Ryan R Richmond,
Matthew Rings
Publication year - 2018
Publication title -
military medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.442
H-Index - 67
eISSN - 1930-613X
pISSN - 0026-4075
DOI - 10.1093/milmed/usx118
Subject(s) - visual acuity , medicine , abca4 , ophthalmology , optometry , active duty , navy , retinopathy , serous fluid , military personnel , diabetes mellitus , history , biochemistry , chemistry , archaeology , gene , phenotype , endocrinology
Central serous retinopathy (CSR) is a disease process that involves accumulation of serous fluid within the macular retina. This fluid accumulation can temporarily or permanently disrupt vision and in many patients is often a recurrent problem. This case describes recurrent CSR in an experienced U.S. Naval F/A-18 fighter pilot. The patient had been troubled by recurrent CSR for several years which required him to be removed from a flying status. After several episodes and treatment with laser photocoagulation and finasteride, the patient's vision and disease process stabilized, but with permanent defective visual acuity in the right eye. There have been many case reports documenting CSR in active duty military aviators worldwide, including flying pilots who have residual permanent loss of visual acuity; however, this is the first U.S. Naval pilot who has been granted a waiver to return to unrestricted flight status with permanent defective visual acuity.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom